AQR Inhibitors
AQR inhibitors, also known as autophagy-related (AQR) inhibitors, represent a class of chemical compounds that have garnered significant attention within the realm of cellular biology and molecular research. These inhibitors are designed to modulate the process of autophagy, a fundamental cellular mechanism responsible for degrading and recycling damaged or unnecessary cellular components. Autophagy plays a pivotal role in maintaining cellular homeostasis, responding to various environmental stressors, and ensuring the proper turnover of organelles and macromolecules. AQR inhibitors, therefore, are valuable tools for scientists seeking to dissect the intricate machinery of autophagy and understand its diverse functions in health and disease.
The mechanisms of action of AQR inhibitors can vary widely, but they all share a common goal: to interfere with the intricate autophagic pathway at specific points. Some AQR inhibitors, such as hydroxychloroquine and chloroquine, disrupt lysosomal function by impairing acidification, thereby hindering the final step of autophagic degradation. Others, like bafilomycin A1, target the V-ATPase proton pump, which is essential for lysosomal acidification. Additionally, certain compounds like 3-methyladenine and wortmannin inhibit class III phosphatidylinositol 3-kinase (PI3K), a key enzyme involved in autophagy initiation. By modulating these critical components of the autophagic machinery, AQR inhibitors enable researchers to gain insights into the complex regulatory processes governing autophagy and its role in various cellular functions, ranging from quality control to cellular adaptation during stress conditions. This class of compounds serves as invaluable tools for advancing our understanding of autophagy-related biology and, by extension, the broader field of cellular and molecular biology.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine inhibits autophagy by impairing lysosomal acidification, which is critical for lysosomal enzyme activity. This inhibition disrupts the degradation process essential for autophagic flux, potentially affecting proteins like AQR by altering their degradation or recycling within the cell. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal function by inhibiting lysosomal acidification, leading to impaired autophagy. This process is crucial for the degradation and recycling of cellular components, including proteins such as AQR, thereby potentially impacting their cellular levels and function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits the V-ATPase proton pump, crucial for maintaining acidic pH in lysosomes. By blocking this pump, it prevents the acidification necessary for lysosomal enzyme activity and autophagosome-lysosome fusion, impacting cellular processes including those involving AQR. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine (3-MA) suppresses autophagy by inhibiting class III PI3K, a key enzyme in the initiation of autophagy. This action can interfere with the cellular turnover and processing of proteins like AQR by reducing autophagic flux. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin irreversibly inhibits PI3K, a critical component of the signaling pathway for autophagy initiation. This inhibition disrupts the autophagic process, potentially affecting the stability and function of proteins such as AQR. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 inhibits autophagy by targeting USP10 and USP13, deubiquitinating enzymes that regulate autophagosome maturation. This suppression can influence the cellular handling and turnover of proteins like AQR. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 inhibits TGF-β signaling, indirectly affecting autophagic flux and processes that could involve the AQR protein, by altering cellular signaling pathways and potentially impacting protein degradation mechanisms. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
SAR405 is a selective inhibitor of Vps34, a class III PI3K involved in the initiation of autophagy. This inhibition can alter the autophagic processing of proteins including AQR, affecting their cellular function and turnover. | ||||||
SBI-0206965 | 1884220-36-3 | sc-507431 | 10 mg | $124.00 | ||
SBI-0206965 inhibits ULK1, a serine/threonine kinase involved in autophagy initiation. This inhibition can disrupt the autophagic degradation pathway, potentially affecting the regulation and function of proteins such as AQR. | ||||||
MRT 68921 | 1190379-70-4 | sc-507429 | 10 mg | $276.00 | ||
MRT68921 blocks ULK1 and ULK2 kinases, key regulators of autophagy induction. By inhibiting these kinases, it prevents the initiation of autophagy, which could impact the cellular dynamics and function of proteins like AQR. | ||||||